Concurrent chemo-radiotherapy for nasopharyngeal carcinoma

Auris Nasus Larynx

Volumn 31, Issue 1, 2004, Pages 43-47

  Okita, Jun ^a   Hatta, Chihiro ^a   Terada, Tomonori ^a   Saeki, Nobuo ^a   Ogasawara, Hiroshi ^a   Kakibuchi, Masao ^a   Kamikonya, Norihiko ^a   Sakagami, Masafumi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Carboplatin (CBDCA); Concurrent chemo radiotherapy (CCRT); Nasopharyngeal carcinoma (NPC); UFT

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; UFT;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; NAUSEA; PATIENT COMPLIANCE; RISK ASSESSMENT; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; EVALUATION STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; TEGAFUR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; URACIL;

EID: 1642355860     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2003.09.004     Document Type: Article

References (20)

1. Sugano H., Sakamoto G., Sawaki S., Hirayama T. Histopathological types of nasopharyngeal carcinoma in low-risk area: Japan. IARC Sci. Publ. 20:1978;27-39.
2. Tamada A., Makimoto K., Yamabe H., Imai J., Hinuma Y., Oyagi A.et al. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan. Cancer. 53:1984;430-440.
3. Qin D.X., Hu Y.H., Yan J.H., Xu G.Z., Cai W.M., Wu X.L.et al. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer. 61:1988;1117-1124.
4. Al-Sarraf M., LeBlanc M., Giri P.G.S., Fu K.K., Cooper J., Vuong T.et al. Chemoradiotherapy versus radiotherapy in patients advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J. Clin. Oncol. 10:1998;219-225.
5. Parliament M., Jha N., Rapp E., Smith C., MacKinnon J., Nabholtz J.M.et al. Concurrent weekly carboplatin and radiotherapy for nasopharyngeal carcinoma: report of a joint phase II study. Radiother Oncol. 58:2001;131-136.
6. Cheng S.H., Jian J.J., Tsai S.Y.C., Chan K.Y.C., Yen L.K., Chu N.M.et al. Prognostic features and treatment outcomes in loco-regionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. Int J. Radiat Oncol. Biol. Physiol. 41:1998;755-762.
7. Cheng S.H., Yen L.K., Jian J.J., Tsai S.Y.C., Chu N.M., Leu S.Y.et al. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J. Radiat Oncol. Biol. Physiol. 50:2001;717-726.
8. Cheng S.H., Tsai S.Y.C., Yen T.K., Jian J.J., Chu N., Chan K.et al. Concomitant radiotherapy and chemotherapy for early-stage nasopharynx carcinoma. J. Clin. Oncol. 18:2000;2040-2045.
9. Chi K.H., Chang Y.C., Chan Y.K., Liu J.M., Law C.K., Lo S.S.et al. A phase II study of carboplatin in nasopharyngeal carcinoma. Oncology. 54:1997;203-207.
10. Cooper J.S., Lee H., Torrey M., Hochster H. Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary collaboration of the intergroup experience. Int J. Radiat Oncol. Biol. Physiol. 47:2000;861-866.
11. Chi K.H., Chang Y.C., Chan W.K., Liu J.M., Law C.K., Lo S.S.et al. A phase II study of carboplatin in nasopharyngeal carcinoma. Oncology. 54:1997;203-207.
12. Chougule P.B., Akhtar M.S., Akerley W., Ready N., Safran H., Mcrae R.et al. Chemo-radiotherapy for advanced inoperable head and neck cancer: a phase II study. Semin. Radiat. Oncol. 9:1999;58-63.
13. Fujii S., Kitano S., Ikenaka K., Shirasaka T. Effect of co-administration of uracil or cytosine on the anti-tumor activity of clinical dose of 1-(2-tetrahydro-furyl)-5-fluorouracil and level of 5-fluorouracil in rodents. Gann. 70:1979;209-214.
14. Tobinai K., Kohno A., Shimada Y., Watanabe T., Tamura T., Takeyama K.et al. Toxicity grading criteria of Japan clinical oncology group. Jpn. J. Clin. Oncol. 23:1993;250-257.
15. Bachouchi M., Cvitkovic E., Azli N., Gasmi J., Cortes-Funes H., Boussen H.et al. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy. J. Natl. Cancer Inst. 82:1990;616-620.
16. Dimery I.W., Legha S.S., Peters L.J., Goepfert H., Oswald M.J. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma. Cancer. 60:1987;943-949.
17. Tannock I., Payne D., Cummings B., Hewitt K., Panzarella T. Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy. Clin. Oncol. 5:1987;629-634.
18. Teo P., Ho J.H., Choy D., Choi P., Tsui K.H. Adjunctive chemotherapy to radical radiation therapy in the treatment of advanced nasopharyngeal carcinoma. Int J. Radiat Oncol. Biol. Phys. 13:1987;679-685.
19. Lin J.C., Jan J.S., Hsu C.Y. Pilot study of concurrent chemotherapy and radiotherapy for stage IV nasopharyngeal cancer. Am. J. Clin. Oncol. 20:1997;6-10.
20. Jeremic B., Shibamoto Y., Stanisavljevic B., Milojevic L., Milicic B., Nikolic L. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol. 43:1997;29-37.